This advice has been withdrawn because Novartis has discontinued ofatumumab (Arzerra).
Ofatumumab will continue to be available for people who need it. Contact Clinigen at managedacess@clinigengroup.com or 01932 842100 for details.
This advice has been withdrawn because Novartis has discontinued ofatumumab (Arzerra).
Ofatumumab will continue to be available for people who need it. Contact Clinigen at managedacess@clinigengroup.com or 01932 842100 for details.